Closed
SectorHealthcare
10.33 -2.73
24h
Min
10.07
Max
10.9
Income | 4.4M -18M |
---|---|
Sales | 3.4M 18M |
Profit margin | -99.678 |
Employees | 131 |
EBITDA | 5.6M -15M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +72.76% upside |
Next Earnings | 24 lis 2025 |
---|
Market Cap | 185M 324M |
---|---|
Previous open | 13.06 |
Previous close | 10.33 |
By Acuity
35%
65%
104 / 371 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 18.33 USD 72.76%
High 25 USD
Low 9 USD
Based on 6 Wall Street analysts offering 12 month price targets forENANTA PHARMACEUTICALS INC - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$